TCG Crossover GP II, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. Common Stock, par value $0.001 per share (DNTH)

Filing Manager: TCG Crossover GP II, LLC
Reporting Manager: TCG Crossover GP II, LLC
Security: Dianthus Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: DNTH
Shares outstanding: 31.9M shares
Disclosed Ownership: 1.5M shares
Ownership: 4.7%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 16:34:05 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
TCG Crossover GP II, LLC	4.7%	1.5M	1.5M	/s/ Craig Skaling	Authorized Signatory
TCG Crossover Fund II, L.P.	4.7%	1.5M	1.5M	/s/ Craig Skaling	Authorized Signatory
Chen Yu	4.7%	1.5M	1.5M	/s/ Craig Skaling	By POA as Attorney-in-Fact